Your browser doesn't support javascript.
loading
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
Lee, Jung Yeon; Park, Sung-Soo; Jeon, Young-Woo; Shin, Seung-Hwan; Yahng, Seung-Ah; Min, Chang-Ki.
Affiliation
  • Lee JY; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park SS; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jeon YW; Department of Hematology, Yeoido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Shin SH; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yahng SA; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea. SAYMD@catholic.ac.kr.
  • Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ckmin@catholic.ac.kr.
J Cancer Res Clin Oncol ; 149(13): 11907-11918, 2023 Oct.
Article de En | MEDLINE | ID: mdl-37418057
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Cancer Res Clin Oncol Année: 2023 Type de document: Article Pays de publication: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Myélome multiple Type d'étude: Clinical_trials / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Cancer Res Clin Oncol Année: 2023 Type de document: Article Pays de publication: Allemagne